SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Anthera Pharmaceuticals, Inc. (ANTH)

ANTH RSS Feed
Add ANTH Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 12/15/2017 11:09:49 AM - Followers: 66 - Board type: Free - Posts Today: 0


 


 Anthera Pharmaceuticals Inc.     


                                              Nasdaq: ANTH


 

Anthera Pharmaceuticals is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company has two product candidates in development.

 

Sollpura is Anthera’s novel biotechnology-derived pancreatic enzyme replacement therapy for the potential treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis.

Blisibimod is Anthera’s BAFF inhibitor for the potential treatment of systemic lupus erythematosus and IgA nephropathy.


Pipeline



                            Contact Info                                                                           
                                                                           

Anthera Pharmaceuticals, Inc. 

25801 Industrial Blvd, Suite B • Hayward, CA 94545



Press Contact: pr@anthera.com


Business Development: bd@anthera.com


 Vendors: ap@anthera.com


 Website: www.anthera.com

 

------>>Latest Developments<<-----

December 06, 2016

J. Craig Thompson promoted to Chief Executive Officer and appointed to the Board of Directors Paul F. Truex appointed as Executive Chairman of the Board Dr. Christopher Henney stepped down as Chairman ...

1
 
         
___________________________________________________________________________________________________________________________________________
Outstanding Share Data
October 31 ,2016,the Company had 41,955,126 common shares issued and outstanding
July 31,2016 the Company had 41,427,352 common shares issued and outstanding
April 27,2016 the Company had 40,987,145 common shares issued and outstanding
February 29,2016 the Company had 40,004,037 common shares issued and outstanding
November 1,2015 the Company had 39,875,405 common shares issued and outstanding
August 1,2015 the Company had 39,703,998 common shares issued and outstanding
May 1,2015 the Company had 35,816,364 common shares issued and outstanding
February 28,2015 the Company had 29,091,773 common shares issued and outstanding
November 10,2014 the Company had 22,939,553 common shares issued and outstanding
____________________________________________________________________________________________________________________________________________

MAJOR HOLDERS

 

68% of the outstanding owned by these longs

Outstanding 42mil minus Major ownership of 28.5mil = 13.5mil free trading float


28.5mil Major Holders in this,15mil Institutions,7.5mil Direct Holders,6mil Mutual Funds= 68% of 42mil os 


http://www.barrons.com/quote/stock/us/xnas/anth?mod=DNH_S

________________________________________________________________


http://finance.yahoo.com/q?s=ANTH

   Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation,

including cardiovascular and autoimmune diseases. We currently have a Phase 2 clinical program, blisibimod.It was just recently approved by FDA to move into

PHASE 3

 

   Blisibimod targets elevated levels of B-cell activating factor (BAFF), which has been associated with a variety of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis, multiple sclerosis, Sjögren's Syndrome, Graves' Disease and others.


  It has taken the lupus research community over 50 years to produce a new therapy. Although it is now a year old, Benlysta (belimumab),

now marketed by GlaxoSmithKline and Human Genome Sciences, is the first human monoclonal antibody for the treatment

of lupus.




  Benlysta had a slow take-off grossing $59.2 million in sales in the last three quarters of 2011, but it was approved in numerous

countries by year's end.
Estimated sales for Benlysta in 2012 are said to be about $230 million, with first annual profits likely by 2015.


  The surprisingly slow uptake of Benlysta allows for blisibimod to develop into a promising drug as

it currently has more desirable features than that of Benlysta.


Blisibimod has a dosing regimen of one injection weekly, compared to that of Benlysta which requires a

series of dosing before the maintenance dose begins. Also, Benlysta has limitations on usage pertaining to

specific patient populations and has not been studied in combination with other biologics.

These attributes of blisibimod including a different mechanism of action, will set it apart from

Benlysta, Global Data concludes.

 

 

SureTrader
Interactive Brokers Advertisement
ANTH
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ANTH News: Anthera Pharmaceuticals Announces Positive Outcome of Interim Futility Analysis in the Phase 3 RESULT Clinical Study of Sollp... 12/11/2017 08:30:00 AM
ANTH News: Proxy Statement (definitive) (def 14a) 12/04/2017 06:17:08 AM
ANTH News: Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) 11/29/2017 04:07:00 PM
ANTH News: Notice of Effectiveness (effect) 11/28/2017 06:01:55 AM
ANTH News: Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) 11/20/2017 06:11:21 AM
PostSubject
#2156   In again - maybe my wet dream of Klinsmann 12/15/17 11:09:49 AM
#2155   Look at premarket klinsmann!! 2 dolars touched!! Today jpowellvlc 12/11/17 08:47:05 AM
#2154   Hi jpowellvlc, how are you doing?!? Sold on Klinsmann 12/09/17 07:46:12 AM
#2153   hi klinsmann, how are you? jpowellvlc 12/09/17 05:34:36 AM
#2152   This 2 dólars Will fall Soon!!! jpowellvlc 11/29/17 01:32:54 PM
#2151   Smart move! A nice upward building on a Klinsmann 11/28/17 06:09:43 PM
#2150   Hello friend!!! I come back with 6000 shares jpowellvlc 11/28/17 03:52:06 PM
#2149   Good to hear you my friend! ANTH is Klinsmann 11/22/17 11:13:31 AM
#2148   Hello Mr. Klinsmann, how are you doing? jpowellvlc 11/22/17 11:06:22 AM
#2147   Perfect timing my friend!!! Klinsmann 11/20/17 09:52:13 AM
#2146   Looks like this is gonna pop real big Tdash 11/15/17 02:54:05 PM
#2145   Very thanks for your posts klinsmann, jpowellvlc 11/15/17 02:47:56 PM
#2144   Great to hear that ANTH gains can help Klinsmann 11/15/17 02:40:30 PM
#2143   I would have liked to endure friend, but jpowellvlc 11/15/17 02:37:31 PM
#2142   Jep, very bullish. Just wanted to tell you, Klinsmann 11/15/17 02:30:58 PM
#2141   Sold @2.3 !! WoW 4000 bucks to my jpowellvlc 11/15/17 02:25:49 PM
#2140   wow, I already burn the money in hands! jpowellvlc 11/15/17 12:57:31 PM
#2139   Breaking out above 6 months high... Klinsmann 11/15/17 12:53:33 PM
#2138   Come on!! Good good what a surprise jpowellvlc 11/14/17 03:30:58 PM
#2137   Above 2$ eod my friend :) Klinsmann 11/14/17 03:27:21 PM
#2136   Yes, good sign, maybe they were shaking the tree jpowellvlc 11/14/17 10:26:08 AM
#2135   Turning green right now... Klinsmann 11/14/17 10:23:38 AM
#2134   I am Hoping for 2 weekly close at jpowellvlc 11/14/17 09:36:03 AM
#2133   Chart uptrend still intact. No need to shoot Klinsmann 11/14/17 09:25:41 AM
#2132   It seems that no. jpowellvlc 11/14/17 09:14:41 AM
#2131   As anticipated, gonna leave 1's forever. Has been Klinsmann 11/10/17 02:49:26 PM
#2130   $APTH Nice action today. $2.12 +14%. findit 11/10/17 11:46:11 AM
#2129   Great news! Finally leaving the 1´s behind forever imo Klinsmann 11/09/17 12:57:24 PM
#2128   Moved up again off of the 1,40 bottom. Klinsmann 11/04/17 03:58:42 AM
#2127   nice little shakey wakey now for the rippy wippy TrendTrade2016 10/04/17 09:44:45 AM
#2126   Nice! Trend-Setter 10/04/17 09:22:13 AM
#2125   $ANTH broke $2 after hours!!! Tomorrow should be TheInvincibleBull 10/03/17 04:22:03 PM
#2124   Told everyone ANTH WOULD go ballistic real soon!! makingbiigdough 10/03/17 04:21:59 PM
#2123   weekly 50 day 5 dolla TrendTrade2016 10/03/17 03:36:00 PM
#2122   I'm thinking 3.16 charliewho 10/03/17 03:33:07 PM
#2121   2.29 target TrendTrade2016 10/03/17 03:28:19 PM
#2120   U mean it didn't happen yet?? charliewho 10/03/17 03:25:49 PM
#2119   Beautiful day for ANTH! 1,30's look great right Klinsmann 10/03/17 03:14:08 PM
#2118   get ready for ANTH explosion!! TrendTrade2016 10/03/17 03:09:36 PM
#2117   Its a low market Biotech witha phase3 zino 10/03/17 03:04:47 PM
#2116   ANTH is going to go ballistic soon!!! Adding makingbiigdough 09/26/17 05:00:53 AM
#2115   Yes! I'm continuing to add.:-) MBD makingbiigdough 09/25/17 03:17:53 PM
#2114   Jep, extremely thin after RS. Everyone has been Klinsmann 09/25/17 03:07:40 PM
#2113   Feel the same way my friend! Waaaay oversold makingbiigdough 09/25/17 03:04:18 PM
#2112   Welcome :) To me it already appears much more Klinsmann 09/25/17 02:48:48 PM
#2111   Appears to be high risk reward play. bb money 09/25/17 02:22:16 PM
#2110   Agreed klinsmann! I'm in! :-)MBD makingbiigdough 09/25/17 12:12:44 PM
#2109   https://seekingalpha.com/article/4104087-anthera-looks-redeem-failures Inoviorulez 09/05/17 05:14:43 PM
#2108   Nice reversal in the making off of a Klinsmann 08/30/17 02:15:28 PM
#2107   Good news - looks like settled around 1,40. Klinsmann 08/14/17 01:08:33 PM
PostSubject